Since a BBB-penetrating GDNF was neuroprotective in the 6-hydroxydopamine mouse model of PD at the low dose of 1 mg/kg BW, it is unclear why negative results were observed in the MTPT primate model. Here, GDNF is linked to Parkinson disease.